Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

UnitedHealth stock price steadies after 20% wipeout as Medicare Advantage rates loom

UnitedHealth stock price steadies after 20% wipeout as Medicare Advantage rates loom

UnitedHealth shares rose 1.2% to $286.15 early Wednesday after plunging nearly 20% Tuesday, following a draft Medicare Advantage rate update and a weak 2026 outlook. The draft proposed a 0.09% average payment increase for 2027, far below expectations, triggering an $80 billion selloff in managed care stocks. UnitedHealth expects 2026 revenue to fall to just under $439 billion, with Medicare Advantage membership dropping by up to 1.4 million.
Apple stock price barely moves as earnings near; iPhone demand and AI push in focus

Apple stock price barely moves as earnings near; iPhone demand and AI push in focus

Apple shares rose 0.04% to $258.37 in early New York trading Wednesday ahead of Thursday’s earnings report. Analysts expect the strongest iPhone sales growth in over four years, with investors watching for updates on AI initiatives and services. JPMorgan raised its price target to $315, while Jefferies cut theirs. Regulatory scrutiny and rising component costs remain concerns.
Tesla stock (TSLA) slips at the open as earnings day lands — what Wall Street wants from Musk

Tesla stock (TSLA) slips at the open as earnings day lands — what Wall Street wants from Musk

Tesla shares fell about 1% to $430.90 in early Wednesday trading as investors awaited fourth-quarter results due after the bell. The company reported 418,227 vehicle deliveries and record energy storage deployments last quarter. Tesla and Pilot Travel Centers announced a Semi Charger rollout, targeting summer 2026 openings. Analysts expect a 3.6% drop in sales and a 40% decline in adjusted profit for the quarter.
Micron stock jumps again as $24 billion Singapore fab plan fans AI memory shortage trade

Micron stock jumps again as $24 billion Singapore fab plan fans AI memory shortage trade

Micron shares rose 3% in early trading Wednesday after the company began building a $24 billion wafer fab in Singapore tied to its NAND expansion. The move follows a 5.4% gain Tuesday and comes as chip stocks rallied ahead of the Federal Reserve decision. The Singapore plant is expected to add 1,600 jobs and ramp up production by late 2028. Investors anticipate rising demand for memory chips from AI servers and data centers.
Nvidia stock up early after Reuters report on China H200 approvals, with Fed decision ahead

Nvidia stock up early after Reuters report on China H200 approvals, with Fed decision ahead

Nvidia shares rose 1.1% to $188.52 early Wednesday after China approved ByteDance, Alibaba, and Tencent to buy over 400,000 H200 AI chips, Reuters reported. The approvals come with strict conditions, and some sources say licenses remain too restrictive for orders. Chip stocks rallied broadly, with Broadcom up 2.4% and the VanEck Semiconductor ETF up 2.1%. Investors await the Federal Reserve decision and megacap tech earnings later today.
UPS stock price swings as 30,000-job cut plan and 2026 outlook land after the bell

UPS stock price swings as 30,000-job cut plan and 2026 outlook land after the bell

UPS shares closed up 0.2% at $107.20 after the company announced plans to cut up to 30,000 jobs and shut 24 buildings in early 2026. Fourth-quarter adjusted profit reached $2.38 per share on $24.5 billion revenue. UPS projected 2026 revenue near $89.7 billion and a 9.6% operating margin. The Teamsters union criticized the proposed buyout program.
Why Gilead stock hit a fresh 52-week high as Medicare targets Biktarvy and earnings loom

Why Gilead stock hit a fresh 52-week high as Medicare targets Biktarvy and earnings loom

Gilead Sciences shares rose 2.3% to $140.97 Tuesday, hitting a 52-week high after Medicare named its HIV drug Biktarvy for price negotiations starting in 2028. Trading volume topped 10.5 million shares. CEO Daniel O’Day sold 115,640 shares last week under a pre-set plan. Gilead will report fourth-quarter and full-year results after markets close on Feb. 10.
HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA Healthcare shares surged 7.1% to $505.84 after the company raised its 2026 profit outlook and approved a new $10 billion share buyback. Fourth-quarter revenue rose 6.7% to $19.51 billion, with net income at $1.88 billion. Investors remain cautious as ACA exchange subsidies expire, potentially reducing patient volumes. The board also declared a $0.78 quarterly dividend, payable March 31.
Coinbase stock in focus: Cantor’s $277 call clashes with UK ad ban as Fed looms

Coinbase stock in focus: Cantor’s $277 call clashes with UK ad ban as Fed looms

Coinbase shares fell 1.2% to $210.83 in after-hours trading Tuesday, despite Cantor Fitzgerald starting coverage with an Overweight rating and a $277 price target. Britain’s ad regulator banned a Coinbase campaign, saying it downplayed crypto risks; Coinbase disputed the ruling. Bitcoin rose 0.7% to $89,313, while Ether gained 2.6%. Coinbase’s next earnings report is pending.
Rocket Lab stock jumps, but Neutron setback keeps investors on edge ahead of February results

Rocket Lab stock jumps, but Neutron setback keeps investors on edge ahead of February results

Rocket Lab shares rose 8% Tuesday before slipping after hours, following a recent Neutron Stage 1 tank rupture that cast uncertainty on the rocket’s launch timeline. The stock traded near $87, up from $80.48, after rebounding from a 9.5% drop Monday. Investors await the late-February earnings call for updates on the Neutron program. The company also secured an $816 million U.S. defense contract.

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
Go toTop